Manufacturers Can Assist Other Stakeholders in COVID Battle

As the new coronavirus continues its spread, pharma companies are finding themselves facing a spate of challenges. And although they’ll need to find ways to counter those setbacks, they also can help address issues facing other health care industry stakeholders.

“This is an unprecedented time and one that is full of challenges for companies of all sizes and in all sectors,” observes Mike DeLone, principal at Deloitte Consulting and U.S. life sciences sector leader. “We believe there are five fundamental qualities of resilient leadership that should serve as guiding principles now more than ever: Be genuinely, sincerely empathetic while maintaining a hard, rational line to protect financial performance; put the mission first; aim for speed over elegance; own the narrative; and embrace the long view. While it will take time and effort, this crisis can become an opportunity to move forward and create even more value and positive societal impact.”

© 2024 MMIT
Angela Maas

Angela Maas

Angela has an extensive background of editing, reporting and writing for trade and consumer publications. She has written Radar on Specialty Pharmacy since she joined AIS Health in 2005 and has broad knowledge of the various issues at play within the space. She also has written for Spotlight on Market Access since its 2017 launch. Before joining AIS Health, she was managing editor at Employee Benefit News and Employee Benefit News Canada and managing editor at Hem Aware (a hemophilia publication), Lupus Living and Momentum (a multiple sclerosis publication). She has a B.A. in English and an M.A. in British literature from Arizona State University.

Related Posts

woman-holding-bowel
June 13

Studies Reveal Impact of SonarMD Program on Managing IBD

READ MORE
pills-and-bills
June 13

Report: Led by Anti-Inflammatories, Specialty Drugs Continue Upward Trend

READ MORE
fda-approved-rubber-stamp-with-fda-and-pills-on-craft-paper
June 13

New FDA Approvals: FDA Expanded Mircera’s Patient Population

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today